What was the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on the completion of a significant debt issuance by CVS Health. The company issued and sold various senior notes and floating rate notes, raising a substantial amount of capital.

How much money did CVS Health raise from this debt offering?

CVS Health raised approximately $39,373,930,000 in net proceeds from the sale of the notes, after deducting underwriter discounts and estimated offering expenses.

What are the different types of notes issued and their maturity dates?

The notes issued include Floating Rate Notes due 2020 and 2021, and Senior Notes with fixed rates and maturities in 2020, 2021, 2023, 2025, 2028, 2038, and 2048. Specific interest rates for the senior notes range from 3.125% to 5.050%.

How does this debt issuance relate to the Aetna acquisition?

While this 8-K primarily focuses on the debt offering, it is filed concurrently with information related to the proposed acquisition of Aetna. This debt issuance likely forms part of the financing strategy for that transaction, as indicated by the reference to the S-4 registration statement and joint proxy statement/prospectus filed in connection with the Aetna deal.

CVS 8-K SEC Disclosure — Mar 12, 2018

Summary

This 8-K filing from CVS Health reports on the company's significant debt issuance activity that closed on March 9, 2018. The company successfully sold approximately $39.4 billion in aggregate principal amount of various senior notes and floating rate notes. This substantial capital raise, comprising multiple tranches with maturities ranging from 2020 to 2048 and varying interest rates, is a key financial event for investors to note. The filing also provides context by referencing the ongoing proposed transaction with Aetna, including details about the related registration statement and proxy materials. While this 8-K primarily details the debt offering, it underscores CVS Health's active financial management and its preparations for future strategic moves, such as the Aetna acquisition.

Key Highlights

1CVS Health completed a large debt offering, raising approximately $39.4 billion.
2The offering included a mix of senior notes and floating rate notes with maturities spanning from 2020 to 2048.
3The notes were issued under an Underwriting Agreement with several major financial institutions acting as representatives.
4The net proceeds from the sale of these notes are substantial, indicating a significant financing event for the company.
5The filing references an existing registration statement on Form S-3ASR for these offerings.
6This debt issuance is presented alongside updates regarding the proposed acquisition of Aetna, highlighting the company's active corporate finance activities.
7The closing of the debt sale occurred on March 9, 2018.

CVS HEALTH Corp 8-K Report, Corporate Update (Mar 12, 2018)

Summary

Key Highlights

Frequently Asked Questions